Ascend Wellness Holdings (AAWH) Income from Continuing Operations (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Income from Continuing Operations came in at 29493000.0 in Q1 2026, down 53.15% year-on-year from 62947599.91 in Q1 2025, and up 39.44% quarter-over-quarter from 48703000.0 in Q4 2025.

Ascend Wellness Holdings (AAWH) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 29493000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 53.15% year-over-year to 29493000.0 in Q1 2026; TTM through Mar 2026 was 128428000.0, a 49.18% decrease from a year earlier, with the FY2025 full-year figure at 118193000.0, down 39.06% from the prior year.
  • Income from Continuing Operations rose to 29493000.0 in Q1 2026 per AAWH's latest filing, from 48703000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 841000.0 in Q2 2023 and bottomed at 48703000.0 in Q4 2025.
  • The 5-year median for Income from Continuing Operations is 19343000.0 (2023), against an average of 21281941.18.
  • Across the five-year window, Income from Continuing Operations jumped 103.97% in 2023 and plunged 2690.25% in 2024, its largest moves.
  • Year by year, Income from Continuing Operations stood at 15050000.0 in 2022, then slipped by 28.52% to 19343000.0 in 2023, then advanced by 13.19% to 16791000.0 in 2024, then plunged by 190.05% to 48703000.0 in 2025, then jumped by 39.44% to 29493000.0 in 2026.
  • Per Business Quant, the three latest AAWH Income from Continuing Operations figures stand at 29493000.0 (Q1 2026), 48703000.0 (Q4 2025), and 25825000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn -29.49 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -29.49 Mn
Dec 31, 2025 -48.70 Mn
Sep 30, 2025 -25.83 Mn
Jun 30, 2025 -24.41 Mn
Mar 31, 2025 -19.26 Mn
Dec 31, 2024 -16.79 Mn
Sep 30, 2024 -28.26 Mn
Jun 30, 2024 -21.78 Mn
Mar 31, 2024 -18.16 Mn
Dec 31, 2023 -19.34 Mn
Sep 30, 2023 -11.24 Mn
Jun 30, 2023 841,000.00
Mar 31, 2023 -18.47 Mn
Dec 31, 2022 -15.05 Mn
Sep 30, 2022 -16.86 Mn
Jun 30, 2022 -21.17 Mn
Mar 31, 2022 -27.82 Mn
Dec 31, 2021 -16.51 Mn
Sep 30, 2021 -13.03 Mn
Jun 30, 2021 -44.90 Mn